IMPACT OF THE INTERNATIONAL REFERENCE PRICING ON ACCESS TO STANDARD THERAPY DRUGS FOR ASTHMA AND COPD

被引：0
|
作者：
Visnansky, M. [1 ]
Kababikova, D. [1 ]
机构：
[1] Univ Vet Med & Pharm Kosice, Kosice, Slovakia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1234
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS64
引用
收藏
页码：A560 / A560
页数：1
相关论文
共 45 条
  • [31] Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma Registry
    Le, Tham T.
    Price, David B.
    Erhard, Clement
    Cook, Bill
    Quinton, Anna
    Katial, Rohit
    Christoff, George C.
    Perez-de-Llano, Luis
    Altraja, Alan
    Bergeron, Celine
    Bourdin, Arnaud
    Koh, Mariko Siyue
    Lehtimaeki, Lauri
    Mahboub, Bassam
    Papadopoulos, Nikolaos G.
    Pfeffer, Paul
    Rhee, Chin Kook
    Carter, Victoria
    Martin, Neil
    Tran, Trung N.
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 1055 - 1069
  • [32] RETROSPECTIVE ANALYSIS COMPARING THE IMPACT OF BIOLOGICS VERSUS STANDARD THERAPY IN PATIENTS HOSPITALIZED FOR ASTHMA EXACERBATION
    Gupta, Sushan
    Mohta, Avani
    Ghimire, Prabina
    Thameem, Danish
    CHEST, 2023, 164 (04) : 4928A - 4928A
  • [33] THE IMPACT OF INTERNATIONAL REFERENCE PRICING (IRP) IN FRANCE, ITALY, SPAIN, UNITED KINGDOM, AND CANADA TO NEW AND EXISTING MARKETED MEDICATIONS
    Chu, N.
    Runyan, A.
    Walker, O.
    Farinas, A.
    Bruni, Severi D.
    VALUE IN HEALTH, 2020, 23 : S527 - S528
  • [34] Response to Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma Registry [Letter]
    Agussalim, Agussalim
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 1127 - 1128
  • [35] Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia
    Marshall, JK
    Grootendorst, PV
    O'Brien, BJ
    Dolovich, LR
    Holbrook, AM
    Levy, AR
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 166 (13) : 1655 - 1662
  • [36] Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia
    Jefferson Antonio, Buendia
    Patino, Diana Guerrero
    Lopez Moreno, Melisa
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (02) : 299 - 305
  • [37] The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs
    Ti, Lianping
    Socias, Maria Eugenia
    Wood, Evan
    Milloy, M-J
    Nosova, Ekaterina
    DeBeck, Kora
    Kerr, Thomas
    Hayashi, Kanna
    PLOS ONE, 2018, 13 (03):
  • [38] BUDGET IMPACT ANALYSIS OF TIOTROPIUM BROMIDE VERSUS IPRATROPIUM BROMIDE ON THE TOP OF STANDARD THERAPY IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN RUSSIAN FEDERATION
    Kulikov, A.
    Komarov, I
    VALUE IN HEALTH, 2012, 15 (04) : A53 - A53
  • [39] ESTIMATING THE BUDGET IMPACT OF ADDING OMALIZUMAB TO STANDARD THERAPY IN PATIENTS WITH UNCONTROLLED SEVERE ALLERGIC ASTHMA FROM PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
    Suzuki, C.
    Santoni, N. B.
    Silva, N. L.
    VALUE IN HEALTH, 2013, 16 (03) : A232 - A233
  • [40] Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile
    Calzetta, Luigino
    Ludovica Ritondo, Beatrice
    de Marco, Patrizia
    Cazzola, Mario
    Rogliani, Paola
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (04) : 579 - 581
12345